Patents by Inventor Weiwei Guo

Weiwei Guo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210097063
    Abstract: In an embodiment, the disclosed technologies include extracting, from at least one search log, session data including at least three semantically related queries and corresponding timestamp data; using the session data, creating a training sequence that includes source query data, context query data, and target query data, the source query data having both a temporal relationship and a lexical relationship to the target query data and the context query data having a temporal relationship to the source query data; creating a learned model by, using a machine learning-based modeling process, learning a mapping of a semantic representation of the context query data and the source query data to a semantic representation of the target query data; in response to a new query, using the learned model to generate at least one recommended query that is semantically related to the new query.
    Type: Application
    Filed: September 26, 2019
    Publication date: April 1, 2021
    Inventors: Zhong Yi Wan, Weiwei Guo, Michaeel M. Kazi, Huiji Gao, Bo Long
  • Patent number: 10962626
    Abstract: The embodiment of the present application discloses a data transmission method, device, and radar device, and relates to the field of communication technologies, wherein the method is applied to a radar device, including: determining the starting data acquisition location as the target location; obtaining data acquired by the radar device during the process of rotating by a preset angle from the target location, wherein the preset angle is an angle within a range of (0°, MaxA), and MaxA indicates the maximum rotation angle; packaging the acquired data to generate a target data package; Sending the target data package to the destination device. The data is transmitted by using the solution provided by the embodiment of the present application, and the data delay is reduced.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: March 30, 2021
    Inventors: Weiwei Guo, Kunlin Yu, Chao Sho (Jiang)
  • Publication number: 20200311146
    Abstract: A neural related query generation approach in a search system uses a neural encoder that reads through a source query to build a query intent vector. The approach then processes the query intent vector through a neural decoder to emit a related query. By doing so, the approach gathers information from the entire source query before generating the related query. As a result, the neural encoder-decoder approach captures long-range dependencies in the source query such as, for example, structural ordering of query keywords. The approach can be used to generate related queries for long-tail source queries, including long-tail source queries never before or not recently submitted to the search system.
    Type: Application
    Filed: March 28, 2019
    Publication date: October 1, 2020
    Inventors: Weiwei Guo, Lin Guo, Jianling Zhong, Huiji Gao, Bo Long
  • Publication number: 20200287805
    Abstract: Methods of processing a packet, APs, ACs and non-transitory machine-readable storage mediums are provided in examples of the present disclosure. In one aspect, an AP receives an Internet-of-Things data packet sent by an Internet-of-Things sensor, wherein a sensor identifier of the Internet-of-Things sensor is carried in the Internet-of-Things data packet; and sends the received Internet-of-Things data packet to an AC such that the AC processes the Internet-of-Things data packet based on the sensor identifier.
    Type: Application
    Filed: November 28, 2017
    Publication date: September 10, 2020
    Inventors: Wenqun LI, Weiwei GUO
  • Patent number: 10633342
    Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: April 28, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: Emily Charlotte Cherney, Weifang Shan, Liping Zhang, David K. Williams, Weiwei Guo, Audris Huang, James Aaron Balog
  • Publication number: 20200104427
    Abstract: Techniques for providing a personalized neural query auto-completion pipeline are disclosed herein. In some embodiments, a computer system, in response to detecting user-entered text that has been entered by a user in a search field of a search engine, generates auto-completion candidates based on the user-entered text and a corresponding frequency level for each one of the auto-completion candidates, ranks the auto-completion candidates based on profile data of the user using a neural network model, and causes at least a portion of the plurality of auto-completion candidates to be displayed in an auto-complete user interface element of the search field within the user interface of the computing device of the user based on the ranking prior to the user-entered text being submitted by the user as part of a search query.
    Type: Application
    Filed: September 28, 2018
    Publication date: April 2, 2020
    Inventors: Bo Long, Huiji Gao, Weiwei Guo, Sida Wang
  • Publication number: 20200095231
    Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
    Type: Application
    Filed: May 10, 2018
    Publication date: March 26, 2020
    Inventors: James Aaron BALOG, Emily Charlotte CHERNEY, Liping ZHANG, Audris HUANG, Weifang SHAN, David K. WILLIAMS, Xiao ZHU, Weiwei GUO
  • Publication number: 20200049792
    Abstract: The embodiment of the present application discloses a data transmission method, device, and radar device, and relates to the field of communication technologies, wherein the method is applied to a radar device, including: determining the starting data acquisition location as the target location; obtaining data acquired by the radar device during the process of rotating by a preset angle from the target location, wherein the preset angle is an angle within a range of (0°, MaxA), and MaxA indicates the maximum rotation angle; packaging the acquired data to generate a target data package; Sending the target data package to the destination device. The data is transmitted by using the solution provided by the embodiment of the present application, and the data delay is reduced.
    Type: Application
    Filed: March 5, 2018
    Publication date: February 13, 2020
    Inventors: Weiwei Guo, Kunlin Yu, Chao Sho (Jiang)
  • Patent number: 10399933
    Abstract: There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: September 3, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: James Aaron Balog, Weiwei Guo, Audris Huang, Jay A. Markwalder, Weifang Shan, David K. Williams, Susheel Jethanand Nara, Saumya Roy
  • Publication number: 20190135758
    Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
    Type: Application
    Filed: May 4, 2017
    Publication date: May 9, 2019
    Inventors: Emily Charlotte CHERNEY, Weifang SHAN, Liping ZHANG, David K. WILLIAMS, Weiwei GUO, Audris HUANG, James Aaron BALOG
  • Publication number: 20190092729
    Abstract: Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
    Type: Application
    Filed: November 5, 2015
    Publication date: March 28, 2019
    Inventors: Hilary Plake BECK, Juan Carlos JAEN, Maksim OSIPOV, Jay Patrick POWERS, Maureen Kay REILLY, Hunter Paul SHUNATONA, James Ross WALKER, Mikhail ZIBINSKY, James Aaron BALOG, David K. WILLIAMS, Weiwei GUO
  • Patent number: 10206893
    Abstract: Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: February 19, 2019
    Assignee: Flexus Biosciences, Inc.
    Inventors: Hilary Plake Beck, Juan Carlos Jaen, Maksim Osipov, Jay Patrick Powers, Maureen Kay Reilly, Hunter Paul Shunatona, James Ross Walker, Mikhail Zibinsky, James Aaron Balog, David K. Williams, Jay A. Markwalder, Steven P. Seitz, Emily Charlotte Cherney, Liping Zhang, Weifang Shan, Weiwei Guo, Audris Huang
  • Patent number: 10167254
    Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: January 1, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: James Aaron Balog, Emily Charlotte Cherney, Weiwei Guo, Audris Huang, Jay A. Markwalder, Steven P. Seitz, Weifang Shan, David K. Williams, Natesan Murugesan, Susheel Jethanand Nara, Saumya Roy, Soodamani Thangavel, Ramesh Kumar Sistla, Srinivas Cheruku, Srinivasan Thangathirupathy, Yadagiri Kanyaboina, Nagalakshmi Pulicharla
  • Publication number: 20180325889
    Abstract: Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
    Type: Application
    Filed: November 5, 2015
    Publication date: November 15, 2018
    Inventors: Hilary Plake BECK, Juan Carlos JAEN, Maksim OSIPOV, Jay Patrick POWERS, Maureen Kay REILLY, Hunter Paul SHUNATONA, James Ross WALKER, Mikhail ZIBINSKY, James Aaron BALOG, David K. Williams, Jay A. MARKWALDER, Steven P. SEITZ, Emily Charlotte CHERNEY, Liping ZHANG, Weifang SHAN, Weiwei GUO, Audris HUANG
  • Publication number: 20180183754
    Abstract: An access point (AP), deployed at a user network side, identifies a type of a packet received from a wireless client at the user network sid and performs a tunnel encapsulation on the packet if the packet is a Dynamic Host Configuration Protocol (DHCP) request packet to generate a tunnel encapsulated DHCP request packet. The AP sends the tunnel encapsulated DHCP request packet to an access controller (AC) deployed at a cloud platform side. The AP performs a tunnel de-capsulation on a DHCP response packet returned from the AC to generate a tunnel de-capsulated DHCP response packet, and sends the tunnel de-capsulated DHCP response packet to the wireless client. The tunnel de-capsulated DHCP response packet is loaded with address information allocated by the AC.
    Type: Application
    Filed: October 27, 2015
    Publication date: June 28, 2018
    Inventor: Weiwei GUO
  • Publication number: 20180072660
    Abstract: There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
    Type: Application
    Filed: April 1, 2016
    Publication date: March 15, 2018
    Inventors: James Aaron Balog, Weiwei Guo, Audris Huang, Jay A. Markwalder, Weifang Shan, David K. Williams, Susheel Jethanand Nara, Saumya Roy
  • Patent number: D887484
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: June 16, 2020
    Assignee: Shenzheng Hua Sheng Ao Lai Industrial Co. Ltd
    Inventor: Weiwei Guo
  • Patent number: D889529
    Type: Grant
    Filed: January 2, 2019
    Date of Patent: July 7, 2020
    Inventor: Weiwei Guo
  • Patent number: D911429
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: February 23, 2021
    Inventor: Weiwei Guo
  • Patent number: D923186
    Type: Grant
    Filed: January 2, 2019
    Date of Patent: June 22, 2021
    Inventor: Weiwei Guo